Your browser doesn't support javascript.
loading
Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma.
Hattori, Yutaka; Ikeda, Yurika; Suzuki, Yuya; Ichikawa, Daiju; Matsushita, Maiko.
Affiliation
  • Hattori Y; Division of Clinical Physiology and Therapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan. hattori-yt@pha.keio.ac.jp.
Br J Haematol ; 165(5): 728-31, 2014 Jun.
Article in En | MEDLINE | ID: mdl-24611901
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, p53 / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2014 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, p53 / Multiple Myeloma Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2014 Document type: Article Affiliation country: Japan